Abstract
Hepatocyte growth factor (HGF) is associated with subclinical and clinical atherosclerosis. However, the significance of change in HGF and development of atherosclerotic disease is unknown. In a large and diverse population-based cohort, we report that change in the biomarker HGF is an independent predictor of incident CHD.
Original language | English (US) |
---|---|
Pages (from-to) | 30-34 |
Number of pages | 5 |
Journal | American heart journal |
Volume | 213 |
DOIs | |
State | Published - Jul 2019 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine